Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.

Journal of cellular and molecular medicine - 1 Jan 2024

Xing Xiaojing, Liu Meichen, Wang Xuguang, Guo Qianxue, Wang Hongyue, Wang Wenxue

Abstract excerpt

Diffuse large B-cell lymphoma (DLBCL) is difficult to treat due to the high recurrence rate and therapy intolerance, so finding potential therapeutic targets for DLBCL is critical. FK506-binding protein 3 (FKBP3) contributes to the progression of various cancers and is highly expressed in DLBCL, but the role of FKBP3 in DLBCL and its mechanism are not clear. Our study demonstrated that FKBP3 aggravated the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Proliferation

Share to Gene Expression Regulation, Neoplastic

Share to Lymphoma, Large B-Cell, Diffuse

Share to Protein Deglycase DJ-1

Share to Tacrolimus Binding Proteins

Share to Wnt Signaling Pathway

Source

Open in PubMed Open full text

Identifiers

PMID: 37987202
DOI: 10.1111/jcmm.18041
PMCID: PMC10805489

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling.PMID 37987202Read ↗

Beyond ubiquitination: the atypical functions of Fbxo7 and other F-box proteins.Semantic proximity Read ↗

Fbw7 Inhibits the Progression of Activated B-Cell Like Diffuse Large B-Cell Lymphoma by Targeting the Positive Feedback Loop of the LDHA/lactate/miR-223 AxisSemantic proximity Read ↗

Gsk3β and Tomm20 are substrates of the SCFFbxo7/PARK15 ubiquitin ligase associated with Parkinson's disease.Semantic proximity Read ↗

FOXP1-GINS1 axis promotes DLBCL proliferation and directs doxorubicin resistanceSemantic proximity Read ↗

FOXO3a‐dependent Parkin regulates the development of gastric cancer by targeting ATP‐binding cassette transporter E1Semantic proximity Read ↗

FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas.Semantic proximity Read ↗

CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinomaSemantic proximity Read ↗

Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradationSemantic proximity Read ↗

Identification and Verification of Cdk5 Phosphorylated Deubiquitinating Enzyme BRCC3Semantic proximity Read ↗

LncRNA SBF2-AS1 Promotes Diffuse Large B-Cell Lymphoma Growth by Regulating FGFR2 via Sponging miR-494-3pSemantic proximity Read ↗

p53-PHLDA3-Akt Network: The Key Regulators of Neuroendocrine Tumorigenesis.Semantic proximity Read ↗

PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.